Royalty Pharma plc (RPRX) Free Cash Flow
Royalty Pharma plc (RPRX) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2020-12-31 | $2.14B |
| 2021-12-31 | $2.02B |
| 2022-12-31 | $2.14B |
| 2023-12-31 | $2.99B |
| 2024-12-31 | $2.77B |
| 2025-12-31 | $2.49B |
How RPRX compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| BDX | Becton Dickinson and Company | $2.67B |
| ZTS | Zoetis Inc. Class A | $2.28B |
| IQV | IQVIA Holdings Inc. | $2.05B |
| VTRS | Viatris Inc. | $1.94B |
| ZBH | Zimmer Biomet Holdings Inc. | $1.42B |
These are five companies in the same sector as RPRX with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Royalty Pharma plc Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("RPRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RPRX | $61.31 | +1.21% | 2.33M |
| 3 | ||||
| 4 | ||||
| 5 |